Original Article Online Published: 21 Jan 2021 | ||||||||||||
Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study. Hussein G Elsayed, Moayyad Jalal, Anas Almarrakshi, Ahlam Almasaari, Amal Alabulwahab, Fatimah Alhawsawi, Amjad Alharbi, Asmaa Almaddani, Ahmed Zeineldeen.
|
How to Cite this Article |
Pubmed Style Elsayed HG, Jalal M, Almarrakshi A, Almasaari A, Alabulwahab A, Alhawsawi F, Alharbi A, Almaddani A, Zeineldeen A. Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. IJMDC. Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 Web Style Elsayed HG, Jalal M, Almarrakshi A, Almasaari A, Alabulwahab A, Alhawsawi F, Alharbi A, Almaddani A, Zeineldeen A. Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. https://www.ijmdc.com/?mno=47229 [Access: February 07, 2025]. doi:10.24911/IJMDC.51-1611143630 AMA (American Medical Association) Style Elsayed HG, Jalal M, Almarrakshi A, Almasaari A, Alabulwahab A, Alhawsawi F, Alharbi A, Almaddani A, Zeineldeen A. Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. IJMDC. Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 Vancouver/ICMJE Style Elsayed HG, Jalal M, Almarrakshi A, Almasaari A, Alabulwahab A, Alhawsawi F, Alharbi A, Almaddani A, Zeineldeen A. Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. IJMDC, [cited February 07, 2025]; Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 Harvard Style Elsayed, H. G., Jalal, . M., Almarrakshi, . A., Almasaari, . A., Alabulwahab, . A., Alhawsawi, . F., Alharbi, . A., Almaddani, . A. & Zeineldeen, . A. (2021) Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. IJMDC, Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 Turabian Style Elsayed, Hussein G, Moayyad Jalal, Anas Almarrakshi, Ahlam Almasaari, Amal Alabulwahab, Fatimah Alhawsawi, Amjad Alharbi, Asmaa Almaddani, and Ahmed Zeineldeen. 2021. Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. International Journal of Medicine in Developing Countries, Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 Chicago Style Elsayed, Hussein G, Moayyad Jalal, Anas Almarrakshi, Ahlam Almasaari, Amal Alabulwahab, Fatimah Alhawsawi, Amjad Alharbi, Asmaa Almaddani, and Ahmed Zeineldeen. "Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.." International Journal of Medicine in Developing Countries Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 MLA (The Modern Language Association) Style Elsayed, Hussein G, Moayyad Jalal, Anas Almarrakshi, Ahlam Almasaari, Amal Alabulwahab, Fatimah Alhawsawi, Amjad Alharbi, Asmaa Almaddani, and Ahmed Zeineldeen. "Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.." International Journal of Medicine in Developing Countries Online First: 21 Jan, 2021. Web. 07 Feb 2025 doi:10.24911/IJMDC.51-1611143630 APA (American Psychological Association) Style Elsayed, H. G., Jalal, . M., Almarrakshi, . A., Almasaari, . A., Alabulwahab, . A., Alhawsawi, . F., Alharbi, . A., Almaddani, . A. & Zeineldeen, . A. (2021) Real life experience using Imatinib as first line treatment in chronic myeloid leukemia; single Saudi institution study.. International Journal of Medicine in Developing Countries, Online First: 21 Jan, 2021. doi:10.24911/IJMDC.51-1611143630 |